HGEN IMO is dipping because the news was generally perceived as negative, and weak knees investors and day traders, swing traders, profit takers are selling. But the move for a easier to meet endpoint, should quickly cause the sp to rebound, once it is understood. If they are in bed with big pharma, and this EP change was done so they could more easily obtain an EUA, well, somebody is behind Humanigen being allowed to cheat. Are "On ventilation" folks included or excluded from CYDY's s/c trial?

This IMO, HGEN change should have boosted (boost = lil bro of catalyst) CYDY and RLFTF, but shorts apparently (or MM) are hitting us today. I'd say in the long run, in won't effect CYDY, due to if HGEN when/if approved, it will be after we are approved. And we should be approved before RLFTF also. Too many variables therapeutics in the news all over the place and with suspicions, huge money involved, then the deaths piling higher and higher. Is the FDA actually influenced by, or do they have a preference for approving....BP???Huge Merck has a therapeutic with reported 50% reduction in s/c deaths I think 2 months ago (Seeking Alpha) but I can't find anything more on it. The HGEN discussion board of course believes in their drug, yet Dr Patterson says it will show efficacy in only 20% of infected patients. Their Yahoo board continually bashes CYDY.